OneMedNet Corp Files Q2 2024 10-Q
Ticker: ONMDW · Form: 10-Q · Filed: Dec 11, 2024 · CIK: 1849380
| Field | Detail |
|---|---|
| Company | Onemednet CORP (ONMDW) |
| Form Type | 10-Q |
| Filed Date | Dec 11, 2024 |
| Risk Level | medium |
| Pages | 15 |
| Reading Time | 18 min |
| Key Dollar Amounts | $0.0001, $11.50 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, company-update
Related Tickers: ONMD
TL;DR
OneMedNet's Q2 10-Q is in. Check financials for ONMD.
AI Summary
OneMedNet Corp filed its 10-Q for the period ending June 30, 2024. The company, formerly Data Knights Acquisition Corp., is incorporated in Delaware and operates in the commercial physical & biological research sector. Its principal executive offices are located in Surrey, UK. The filing covers the second quarter of fiscal year 2024.
Why It Matters
This filing provides investors with an update on OneMedNet Corp's financial performance and operational status for the second quarter of 2024, crucial for understanding the company's trajectory.
Risk Assessment
Risk Level: medium — As a 10-Q filing, it contains detailed financial information and risk factors that could impact the company's stock performance.
Key Numbers
- 20240630 — Period End Date (The 10-Q covers financial data up to this date.)
- 20241211 — Filing Date (The date the 10-Q was officially submitted to the SEC.)
Key Players & Entities
- OneMedNet Corp (company) — Filer of the 10-Q
- Data Knights Acquisition Corp. (company) — Former name of OneMedNet Corp
- 20240630 (date) — Period of report for the 10-Q
- 20241211 (date) — Filing date of the 10-Q
- DE (location) — State of incorporation
- Surrey, UK (location) — Location of business address
FAQ
What is the primary business of OneMedNet Corp?
OneMedNet Corp operates in the SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH sector, SIC code 8731.
When was the company formerly known as Data Knights Acquisition Corp.?
The company changed its name from Data Knights Acquisition Corp. on March 4, 2021.
What period does this 10-Q filing cover?
This 10-Q filing covers the period of report ending June 30, 2024.
Where is OneMedNet Corp's business address located?
OneMedNet Corp's business address is located at Trident Court, 1 Oakcroft Road, Chessington, Surrey, KT9 1BD, UK.
What is the SEC file number for OneMedNet Corp?
The SEC file number for OneMedNet Corp is 001-40386.
Filing Stats: 4,569 words · 18 min read · ~15 pages · Grade level 18.4 · Accepted 2024-12-11 16:05:27
Key Financial Figures
- $0.0001 — ch registered Common stock, par value $0.0001 per share ONMD The Nasdaq Stock Mar
- $11.50 — of Common Stock at an exercise price of $11.50 per share ONMDW The Nasdaq Stock Ma
Filing Documents
- form10-q.htm (10-Q) — 1013KB
- ex31-1.htm (EX-31.1) — 18KB
- ex31-2.htm (EX-31.2) — 18KB
- ex32-1.htm (EX-32.1) — 8KB
- ex32-2.htm (EX-32.2) — 8KB
- 0001493152-24-049637.txt ( ) — 5166KB
- onmd-20240630.xsd (EX-101.SCH) — 38KB
- onmd-20240630_cal.xml (EX-101.CAL) — 48KB
- onmd-20240630_def.xml (EX-101.DEF) — 233KB
- onmd-20240630_lab.xml (EX-101.LAB) — 349KB
- onmd-20240630_pre.xml (EX-101.PRE) — 296KB
- form10-q_htm.xml (XML) — 647KB
Financial Statements
Financial Statements 1 Unaudited Condensed Consolidated Balance Sheets as of June 30, 2024 and December 31, 2023 1 Unaudited Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2024 and 2023 2 Unaudited Condensed Consolidated Statements of Changes in Temporary Equity and Stockholders' Deficit for the three and six months ended June 30, 2024 and 2023 3 Unaudited Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2024 and 2023 4 Notes to Unaudited Condensed Consolidated Financial Statements 5 Item 2.
Management's Discussion and Analysis of Financial Condition and Results of Operations
Management's Discussion and Analysis of Financial Condition and Results of Operations 16 Item 3.
Quantitative and Qualitative Disclosures About Market Risk
Quantitative and Qualitative Disclosures About Market Risk 25 Item 4.
Controls and Procedures
Controls and Procedures 25 PART II. OTHER INFORMATION 26 Item 1.
Legal Proceedings
Legal Proceedings 26 Item 1A.
Risk Factors
Risk Factors 26 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 26 Item 3. Defaults Upon Senior Securities 26 Item 4. Mine Safety Disclosures 26 Item 5. Other Information 26 Item 6. Exhibits 26
Signatures
Signatures 27 i CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS Certain constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, and of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). All statements other than statements of historical facts contained in this Form 10-Q are forward-looking statements. The forward-looking statements in this Form 10-Q are only predictions. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our business, financial condition, and results of operations. In some cases, you can identify these forward-looking "estimate," "expects," "intend," "may," "ongoing," "plan," "potential," "predict," "project," "should," "will," "would" or the negative of those terms or other similar expressions, although not all forward-looking statements contain those words. We have based these forward-looking results of operations, strategy, short- and long-term business operations and objectives, and financial needs. Our operations involve risks and uncertainties, many of which are outside our control, and any one of which, or a combination of which, could materially affect our results of operations and whether the forward-looking statements ultimately prove to be correct. We have based these forward-looking statements largely on our current expectations and projections about future events and trends that we believe may